Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Ambrisentan

EU orphan designation number: EU/3/10/790
Active ingredient: Ambrisentan
Indication: Treatment of idiopathic pulmonary fibrosis
Sponsor: Gilead Sciences International Ltd
Flowers Building, Granta Park, Abington, Cambridge CB21 6GT United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/10/2010 Centralised Orphan - Designation EMA/OD/029/10 (2010)6935 of 01/10/2010
23/06/2011 Centralised Orphan - Removal of orphan designation from Community Register